About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Massachusetts | 508 Studies

Clinical Trials Prostate CancerMassachusetts

Prostate Cancer Clinical Trials in Massachusetts

Find 508 clinical trials for prostate cancer near Massachusetts. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Massachusetts

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 508 trials

WithdrawnNeratinib in Patients With Metastatic Castration-Resistant Prostate CancerThis research study is examining whether Neratinib has any activity in participants with prostate cancer that has spread and is no longer responding to hormonal treatment.NCT04781374·Boston, Massachusetts and 2 others Active not recruitingAn International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)The purpose of this study is to evaluate the efficacy and safety of 177Lu-PSMA-617 in combination with Standard of Care (SOC), versus Standard of Care alone, in adult male…NCT04720157·Scottsdale, Arizona and 166 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedCabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate CancerPrimary Objective: * To demonstrate the superiority of cabazitaxel plus prednisone at 25 mg/m\^2 (Arm A) or 20 mg/m\^2 (Arm B) versus docetaxel plus prednisone (Arm C) in term of…NCT01308567·Muscle Shoals, Alabama and 166 others

CompletedAn Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair AnomaliesThe purpose of this study is to assess the efficacy, safety, and pharmacokinetics of niraparib in men with metastatic castration-resistant prostate cancer (mCRPC) and…NCT02854436·Tucson, Arizona and 109 others

RecruitingGenomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate CancerThe objective of this study is to see if providing an appropriate therapy based on the genomic testing of prostate tumour tissue will result in an improved clinical response.NCT04812366·Sacramento, California and 8 others

Active not recruitingAndrogen Receptor Signaling and Prostate-Specific Membrane Antigen ExpressionThe goal of this research study is to determine whether hormonal therapies used early in the course of prostate cancer could increase the amount of Prostate-Specific Membrane…NCT05683964·Boston, Massachusetts

CompletedA Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate CancerVaccines made from a gene-modified virus may help the body build an effective immune response to kill tumor cells.NCT00108732·Jacksonville, Florida and 6 others

RecruitingPhase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate CancerThis is an open label, phase I, multi-center study aiming to assess the safety and tolerability in patients with metastatic castration resistant prostate cancer (mCRPC).NCT06801236·La Jolla, California and 12 others

RecruitingPilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CTThis research study is studying a positron emission tomography (PET) agent called 18F-fluciclovine to evaluate how well 18F-fluciclovine-PET scans determine the extent of advanced…NCT06062745·Boston, Massachusetts and 1 other

CompletedEnzalutamide/Leuprolide +/- Abiraterone/Pred in ProstateThis study is comparing the effectiveness of enzalutamide with or without abiraterone acetate for men with high-risk, localized prostate cancer.NCT02268175·Baltimore, Maryland and 3 others

TerminatedSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 (Alobresib) as a Single Agent and In Combination With Enzalutamide in Participants With Metastatic Castrate-Resistant Prostate CancerThis study consists of two phases: Dose Escalation (Phase 1b) and Dose Expansion (Phase 2) The Dose Escalation phase will characterize the safety, tolerability, and determine the…NCT02607228·San Francisco, California and 3 others

RecruitingPrecision-Based Genomics in Prostate CancerBackground: Prostate cancer is the most common cancer and the second leading cause of death in males in the United States.NCT04706663·La Jolla, California and 10 others

RecruitingSequential Testosterone and Enzalutamide Prevents Unfavorable ProgressionAsymptomatic men without pain due to prostate cancer progressing with metastatic CRPC after treatment with combination or sequential ADT + Abi will be treated on a randomized…NCT04363164·San Diego, California and 5 others

CompletedBrachytherapy in Treating Patients With Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Giving radiation therapy through seeds implanted into the prostate may kill more tumor cells.NCT00003312·Birmingham, Alabama and 257 others

CompletedStudy of Enzalutamide in Patients With Castration-resistant Prostate CancerThis research study is evaluating a drug called enzalutamide in metastatic castration resistant prostate cancer.NCT01942837·Boston, Massachusetts and 4 others

CompletedA Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate CancerThis is a randomized, open-label, three-arm, phase 3 study in men with biochemically recurrent prostate cancer and PSA doubling time ≤ 9 months at the time of study entry.NCT03009981·Phoenix, Arizona and 68 others

CompletedDarolutamide in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate CancerThe purpose of the study is to assess the efficacy and safety of BAY1841788 (darolutamide (ODM-201)) in combination with standard androgen deprivation therapy (ADT) and docetaxel…NCT02799602·Chandler, Arizona and 321 others

Active not recruitingFc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced CancerThis study is an open-label, Phase 1, multicenter study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamic (PD) profiles of a novel fragment…NCT03860272·Scottsdale, Arizona and 17 others

CompletedFractionated Docetaxel and Radium 223 in Metastatic Castration-Resistant Prostate CancerThe objective of this study is to determine the maximum safe dose of Ra-223 in combination with fractionated (split doses) docetaxel when given to subjects and to determine the…NCT03737370·Boston, Massachusetts and 3 others

TerminatedJavelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid TumorsAvelumab in combination with talazoparib will be investigated in patients with locally advanced (primary or recurrent) or metastatic solid tumors, including non-small cell lung…NCT03330405·Fayetteville, Arkansas and 65 others

PreviousPage 2 of 26Next

Other Conditions in Massachusetts

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma